ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
Emergency Department Telephone Quitline

This study is ongoing, but not recruiting participants.

Sponsored by: Mayo Clinic
Information provided by: Mayo Clinic
ClinicalTrials.gov Identifier: NCT00394420
  Purpose

The purpose of this preliminary study was to evaluate the intervention completion rate among cigarette smokers enrolled through the Emergency Department (ED) in a tobacco quitline (QL) and to assess the feasibility of a randomized controlled trial assessing the efficacy of this intervention.


Condition Intervention
Tobacco Dependence
Behavioral: Telephone Quitline

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study
Official Title:   A Telephone Quitline Intervention for Smoking Cessation Through the Emergency Department

Further study details as provided by Mayo Clinic:

Primary Outcome Measures:
  • The primary outcome was completion of the QL intervention.

Estimated Enrollment:   40
Study Start Date:   September 2003

Detailed Description:

This pilot study was a prospective, randomized, controlled, un-blinded study using a convenience sample of cigarettes smokers recruited through the ED.

Utilizing a computerized block randomization schedule, subjects were randomized in blocks of four to receive a proactive QL intervention through an established QL or a United States Public Health Service (USPHS) self-help manual. Proactive telephone counseling describes counseling that is initiated by a counselor rather than the subject. Both groups received strong advice to quit from study personnel.

Names and telephone numbers of patients randomized to the QL group were faxed to the QL which then initiated contact with the patient. Multiple contact attempts were made over the following week by telephone. Patients in the QL were instructed to call the QL if they had not been reached in one week. QL counseling involved an initial 45-minute telephone session followed by up to four 10 to 15 minute follow-up sessions around their identified quit date. QL patients not successfully contacted within one week of enrollment were sent a letter inviting them to call as well as information on strategies to help them quit.

  Eligibility
Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes

Criteria

Inclusion Criteria:

  • We enrolled patients aged 18 or older who reported current daily cigarette smoking for at least one year and who indicated an interest in attempting to quit smoking.
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00394420

Locations
United States, Minnesota
Mayo Clinic    
      Rochester, Minnesota, United States, 55905

Sponsors and Collaborators
Mayo Clinic

Investigators
Principal Investigator:     Nicola E. Schiebel, M.D.     Mayo Clinic    
  More Information


Study ID Numbers:   1321-03
First Received:   October 31, 2006
Last Updated:   October 31, 2006
ClinicalTrials.gov Identifier:   NCT00394420
Health Authority:   United States: Institutional Review Board

Study placed in the following topic categories:
Smoking
Mental Disorders
Tobacco Use Disorder
Substance-Related Disorders
Disorders of Environmental Origin
Emergencies

Additional relevant MeSH terms:
Disease Attributes
Pathologic Processes

ClinicalTrials.gov processed this record on September 23, 2008




Links to all studies - primarily for crawlers